Body distribution of SiO₂-Fe₃O₄ core-shell nanoparticles after intravenous injection and intratracheal instillation.

MLA

Smulders, Stijn, et al. “Body Distribution of SiO₂-Fe₃O₄ Core-Shell Nanoparticles after Intravenous Injection and Intratracheal Instillation.” Nanotoxicology, vol. 10, no. 5, 2016, pp. 567–74. EBSCOhost, https://doi.org/10.3109/17435390.2015.1100761.

APA

Smulders, S., Ketkar-Atre, A., Luyts, K., Vriens, H., Nobre, S. D. S., Rivard, C., Van Landuyt, K., Baken, S., Smolders, E., Golanski, L., Ghosh, M., Vanoirbeek, J., Himmelreich, U., & Hoet, P. H. (2016). Body distribution of SiO₂-Fe₃O₄ core-shell nanoparticles after intravenous injection and intratracheal instillation. Nanotoxicology, 10(5), 567–574. https://doi.org/10.3109/17435390.2015.1100761

Chicago

Smulders, Stijn, Ashwini Ketkar-Atre, Katrien Luyts, Hanne Vriens, Sonia De Sousa Nobre, Camille Rivard, Kirsten Van Landuyt, et al. 2016. “Body Distribution of SiO₂-Fe₃O₄ Core-Shell Nanoparticles after Intravenous Injection and Intratracheal Instillation.” Nanotoxicology 10 (5): 567–74. doi:10.3109/17435390.2015.1100761.